Marina Caputo Tommaso Daffara Simonetta Bellone Valentina Mancioppi Paolo Marzullo Gianluca Aimaretti Flavia Prodam
10.3389/fendo.2021.687918
Front Endocrinol (Lausanne)
2021 Jun 22;12:687918.
beckwith-wiedemann syndrome liraglutide obesity syndromic obesity weight
CC BY
https://pubmed.ncbi.nlm.nih.gov/34239499/
Anti-Obesity Agents / therapeutic use Beckwith-Wiedemann Syndrome / complications Liraglutide / therapeutic use Obesity / drug therapy
Anti-Obesity Agents / therapeutic use Beckwith-Wiedemann Syndrome / complications Liraglutide / therapeutic use Obesity / drug therapy Case Reports Adolescent Humans Male Obesity / etiology Treatment Outcome Anti-Obesity Agents Liraglutide
PMC8258411
34239499
Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
2021